News Release More 2021年8月 3日 Summary of Consolidated Financial Results (August 3,2021) [Japanese Standard] 2021年8月 3日 First Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2022 - Supplementary Information 2021年5月11日 Summary of Consolidated Financial Results (For the fiscal year ended March 31, 2021) [Japanese Standard] 2021年5月11日 Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 - Supplementary information 2021年5月 7日 The Revision of Consolidated Financial Forecasts for Fiscal Year Ended March 31, 2021 2021年4月26日 MSD and KYORIN Conclude Distribution Agreement of Gefapixant Citrate, a Treatment for Chronic Cough, in Japan 2021年4月21日 Launch of the Interstitial cystitis "Zymso® Intravesical Solution 50%" 2021年3月31日 KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries Latest IR Events More First Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2021 Summary of consolidated Financial Results [ PDF 160.2 KB ] Supplementary Information [ PDF 588.5 KB ] Top Message Products Under Development IR Events Financial Information Financial Highlights Financial Indicators Business Segment/Main Products Cash Flows Capital Investment/Depreciation/R&D Costs Download Financial Data IR Library Summary of ConsolidatedFinancial Results/Presentation Document Annual Report Stock Information Shareholders Meeting Shareholder Return/Dividends General Information Stock Quote Business Risks Disclaimer FAQ Disclosure Policy
